Compare Revvity Inc (RVTY) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs TeraWulf Inc — how do they compare? Revvity Inc trades at $124.14 (market cap $13.82B), while TeraWulf Inc trades at $16.92 (market cap $8.54B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.23% dividend while TeraWulf Inc pays none. Which is the better fit depends on your goals.
| RVTY | WULF | |
|---|---|---|
Market Cap | $13.82B | $8.54B |
Sector | Technology | Technology |
52-Week High | $130.94 | $28.98 |
52-Week Low | $82.26 | $10.49 |
Enterprise Value | $16.14B | $11.16B |
Dividend Yield | 0.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
WULF trades at $17.86, up 8.18% today, amid a bullish technical signal despite consecutive quarterly earnings misses. The company is pivoting from Bitcoin mining to high-performance computing, securing contracts with Google and FluidStack, and expanding capacity with projects like the Kentucky data campus approved August 24, 2026. However, fundamentals show deep losses with a net income margin of -1,179.94% in 2026 and negative cash flow from operations.
The outlook is mixed: analyst consensus is strongly bullish with a $35.94 price target, but execution risks are high given the costly pivot and persistent unprofitability. Investors face volatility from the business model transition, though institutional interest remains with recent investments from Deutsche Bank and Beacon Pointe Advisors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
